Abstract
(1) Definition and appropriate selection of patients admitted to the trial: all inclusion and exclusion criteria used to select patients must be mentioned in detail. It is also important to know of certain associated diseases (e.g. hypertension, diabetes, etc.) which influence the intensity or duration of bleeding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1977 Martinus Nijhoff, P.O.B. 442, The Hague, The Netherlands
About this chapter
Cite this chapter
Verstraete, M. (1977). The following recommendations are made for trials set up to determine the clinical usefulness of systemic haemostatic agents. In: Haemostatic Drugs. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-1106-8_33
Download citation
DOI: https://doi.org/10.1007/978-94-010-1106-8_33
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-247-2020-0
Online ISBN: 978-94-010-1106-8
eBook Packages: Springer Book Archive